LEXINGTON, Mass.--(BUSINESS WIRE)--EPIX Pharmaceuticals, Inc. (NASDAQ:EPIX) today announced that Margaret Uprichard, Pharm.D., has been appointed to the position of senior vice president, regulatory affairs and quality for the company. In this role, Dr. Uprichard will be responsible for leading all regulatory affairs activities for the company, including developing and maintaining effective regulatory strategies for EPIX’s four lead product candidates currently in clinical trials.
